Published in Gene Therapy Weekly, January 5th, 2006
"However," wrote D.A.M. Heideman and colleagues, VU University Medical Center, "the feasibility to treat tumors in which the effect of the HGF-cMET signaling pathway is less unambiguous or may even be inhibitory on carcinogenesis, such as HCC with NK4...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly